研究發(fā)現(xiàn)血友病藥物可損害心臟(3)
"On the other hand, if it's not excessive bleeding and there are other options to explore, the safety issue may hold you back from doing this."
The treatment did not increase the risk of unwanted clots in veins, regardless of age, the researchers found. It increased the risk of stroke, but not enough to be statistically significant.
Dr. Louis Aledort of the Mount Sinai School of Medicine in New York said in a commentary that 4 percent of the NovoSeven used at his hospital is for non-approved therapy. "At other centers, the rate of off-label use may be even higher," Aledort said.
Levi said hospitals that are quick to give the drug may now want to reconsider that practice.
本站所注明來源為"愛愛醫(yī)"的文章，版權歸作者與本站共同所有，非經(jīng)授權不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個人可與我們
聯(lián)系zlzs@120.net，我們將立即進行刪除處理
熱點圖文
-
AHA家族性高膽固醇血癥科學聲明十大要點
近期，美國心臟學會（AHA）發(fā)布了家族性高膽固醇血癥的相關事宜的科學聲明，...[詳細]
-
[GWICC2015]李焱：心血管疾病患者血糖管理的5個維度
糖尿病與冠心病互為高危因素。當糖尿病與冠心病并存時，患者發(fā)生嚴重不良心血管...[詳細]
